Replies to post #730618 on NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

thanks

I agree with you on BLA because of the absence of individual patient data.
I do not think they will be in any position to start any other trial Direct, pediatric, or another cancer indication without a large financial injection.

How on earth they will be able to sell support 500 to 1000 batches the 12 months after UK approval is a big other question mark to me. A sales department is an investment for which they hardly have any cash. NICE is also a question mark since they could lose approval if they keep refusing to engage with, with an economic model for which they also need cash.

I believe that right after UK approval they will submit an MAA with the EMA and will get approval there soon after (maybe even 6 months) because of the cooperation between the MHRA and the EMA.

I think NWBO will after UK approval be at a crossroads either they will team up with a large pharma for a good financial injection and get things done at double speeds or they will linger stock price/market cap will go back to where we are today and they will not get much done.
So al in all I think Powers will have to make a hard choice accept a deal with big pharma on perhaps less favorable terms or perish.

[RobotDroid]

Cannot expect anything from mute inept nonmanagement at this point.